The clock is ticking towards the ESACT - European Society for Animal Cell Technology Congress starting this Sunday, June 23 in #Edinburgh, Scotland! Ahmed Youssef will be onsite helping to invigorate day one with a talk about #genetherapy #commercialization hosted by Sartorius at 1:30pm. Looking to connect, or can't make it to the talk and want the highlights? We are always accessible at [email protected] or by DM to follow up.
Ascend Advanced Therapies’ Post
More Relevant Posts
-
Say goodbye to animal testing with XCellR8's groundbreaking Acute Toxicity Test! 🚫 Our GLP-accredited lab offers the first truly animal-free preliminary screen for human acute oral toxicity. Learn more about this innovative approach that uses human cell-based methods in animal product-free conditions. Discover how we assess cell membrane integrity and metabolism to provide vital toxicity data without harming animals. Visit our site to learn more! https://lnkd.in/e6TUgxfQ #AcuteToxicityTest #AnimalFreeTesting
-
-
Head of Built Environment & Infrastructure (non-ICT) | Project Lead - Research, MCCC | President - ANZLAA | 2022 CEW Schmidmaier Mayne Scholarship recipient
An important webinar for those that are signatories or interested in signing the Australian or New Zealand openness agreements. This is also a call to action to join Understanding Animal Research Oceania for those that work in the Industry and need support!
Openness around animal research, is becoming widely adopted by life-science organisations all over the world. If you are based in Australia, New-Zealand or an East Asian time zone, come along to the webinar to hear more about why openness matters. Register in advance for this webinar: https://lnkd.in/gqRg-wNM
-
-
What do you think? 🤔 A recent study found that only 5% of #animalstudies lead to human treatments. Is this a wake-up call to improve study design or is it a success? The Center for Reproducible Science at the University of Zurich, an European Animal Research Association (EARA) member, published the results. Study author Benjamin Ineichen attributes the low success rate to many factors, saying "...you have to consider how difficult it is to develop effective new therapies and how great the utility of a drug is for people who suffer from an illness." Where do you stand on the topic? How do we improve the probability of success? Are there limitations in animal studies that are holding us back? Should we design animal experiments to more closely resemble the human trials that may one day follow? #RevolutionizingResearch #invivo
-
Elevate your animal dosing investigation with ALZET® Osmotic Pumps – a sophisticated solution for precise, continuous drug delivery in mice, rats, and other laboratory animals. Say goodbye to frequent handling and stress, embracing a cost-effective approach to chronic dosing. Facilitate targeted delivery with ease, empowering your research team with accurate dosing. https://okt.to/zkIvHL #InnovationInResearch #ALZETPumps
ALZET® Osmotic Infusion Pumps for Continuous Dosing of Laboratory Animals
-
If you are based in Australia, New Zealand, or an East Asian time zone, this is a great opportunity to learn about why openness in animal research matters. Join Bella Lear and Jodi Salinsky to hear about how openness in animal research works, including how to get started, what to expect, and the support and advice available. Register here: https://lnkd.in/eE7gVn2t #ConcordatOpenness #OpenAnimalResearch #AnimalResearch
Openness around animal research, is becoming widely adopted by life-science organisations all over the world. If you are based in Australia, New-Zealand or an East Asian time zone, come along to the webinar to hear more about why openness matters. Register in advance for this webinar: https://lnkd.in/gqRg-wNM
-
-
Vision to replace animal testing 🐭🔬 We still face barriers in testing and research when it comes to moving away from animal testing. Continuing our series of interviews with FRAME Fund for the Replacement of Animals in Medical Experiments's CEO Celean Camp and cellQART®'s CEO Dennis Benkmann, Celean provides insights into testing regulations in different sectors. In testing, regulatory guidelines and official recommendations for animal use remain in place, requiring extensive data provision. Although there are changes, such as the UK government's reformed guidelines, more work and regulation is needed. In research, barriers include incentive to change in the academic sector, funding and publications as references to moving from in vivo to in vitro. Animal research still remains culturally ingrained in certain fields, hindering progress. There's still a long way to go, but we're working tirelessly towards an animal-free future, one step at a time. Stay tuned for the final part of our interview series next week, where we'll talk about how to accelerate this transition! 💡 #nonanimaltesting #biomedical #research #humanandhumane
-
Join us in Ourobionics' mission in ENDING ANIMAL TRIALS! Our CEO John Zandbergen pitches about how eliminating animals trials has to happen by 2035 and how you can have more representable, and translational data with manufactured living human tissue! Learn more at www.ourobionics.com #Bioprinting #science #endanimaltrials
-
-
👋 Join us in Lyon for the EAAP - European Federation of Animal Science Joint International Congress on Animal Science 2023! The event runs from August 26 to September 1, and our very own Estefanía Pérez Calvo, EMEA Principal Scientist will be representing dsm-firmenich with two expert contributions: 📢 Session 34, August 29: Poster entitled "'Benzoic acid reduces environmental impact in fattener pig diets using life cycle assessment" 📢 Session 73, August 31: Presentation entitled "Muramidase inclusion reduces gut inflammation in weaned piglets, especially in high protein diets” We can’t wait to get involved in discussions on #SustainableFarming. See you there! #WeMakeItPossible #WeBringProgressToLife
-
-
Register today for our upcoming event! Let's discuss the importance of preregistration of animal studies together! See you on March 12th! 🗓️ #fin3r #webinar #3Rs #preregistration #animalstudies #refinement #reduction #replacement
Next FIN3R webinar is coming up in a week! Join us to hear more about the importance of the preregistration of the animal studies in improving overall quality or your work. Our speaker, Julia Menon, will present the advantages you can get by using Preclinicaltrials.eu platform. More information 👉 https://fin3r.fi/en/news #webinar #preregistration #fin3r #3Rs #refinement #replacement #reduction #animalstudies #improve
-
